A new piece in the puzzling effect of n-3 fatty acids on atherosclerosis?

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 358-362

  Le Goff, Wilfried ^a,b,c  

^a Sorbonne Universités   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Atherosclerosis; Inflammation; Lipoprotein lipase; Macrophage; N 3 Fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIETARY INTAKE; LASER CAPTURE MICRODISSECTION; LIPID METABOLISM; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 84921479419     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.038     Document Type: Note

References (35)

1. (WHO), WHO The 10 leading causes of death in the world 2011, http://www.who.int/mediacentre/factsheets/fs310/en/.
2. Micha R., Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010, 45:893-905.
3. Chang C.L., Deckelbaum R.J. Omega-3 fatty acids: mechanisms underlying 'protective effects' in atherosclerosis. Current opinion in lipidology 2013, 24:345-350.
4. De Caterina R. n-3 fatty acids in cardiovascular disease. The New England journal of medicine 2011, 364:2439-2450.
5. Harris W.S. Are n-3 fatty acids still cardioprotective?. Current opinion in clinical nutrition and metabolic care 2013, 16:141-149.
6. von Schacky C. Omega-3 fatty acids and cardiovascular disease. Current opinion in clinical nutrition and metabolic care 2004, 7:131-136.
7. Brown A.L., Zhu X., Rong S., et al. Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions. Arteriosclerosis, thrombosis, and vascular biology 2012, 32:2122-2130.
8. Nakajima K., Yamashita T., Kita T., et al. Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor-deficient mice. Arteriosclerosis, thrombosis, and vascular biology 2011, 31:1963-1972.
9. Winnik S., Lohmann C., Richter E.K., et al. Dietary alpha-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation. European heart journal 2011, 32:2573-2584.
10. Zhang L., Geng Y., Xiao N., et al. High dietary n-6/n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1. Journal of atherosclerosis and thrombosis 2009, 16:463-471.
11. Wang S., Wu D., Matthan N.R., Lamon-Fava S., Lecker J.L., Lichtenstein A.H. Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. Atherosclerosis 2009, 204:147-155.
12. Matsumoto M., Sata M., Fukuda D., et al. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis 2008, 197:524-533.
13. Dupasquier C.M., Dibrov E., Kneesh A.L., et al. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions, American journal of physiology. Heart and circulatory physiology 2007, 293:H2394-2402.
14. Saraswathi V., Gao L., Morrow J.D., Chait A., Niswender K.D., Hasty A.H. Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. The Journal of nutrition 2007, 137:1776-1782.
15. Zampolli A., Bysted A., Leth T., Mortensen A., De Caterina R., Falk E. Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis 2006, 184:78-85.
16. Yamashita T., Oda E., Sano T., Ijiru Y., Giddings J.C., Yamamoto J. Varying the ratio of dietary n-6/n-3 polyunsaturated fatty acid alters the tendency to thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse. Thrombosis research 2005, 116:393-401.
17. Wang H.H., Hung T.M., Wei J., Chiang A.N. Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovascular research 2004, 61:169-176.
18. Adan Y., Shibata K., Ni W., et al. Concentration of serum lipids and aortic lesion size in female and male apo E-deficient mice fed docosahexaenoic acid. Bioscience, biotechnology, and biochemistry 1999, 63:309-313.
19. Rudel L.L., Kelley K., Sawyer J.K., Shah R., Wilson M.D. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. Arteriosclerosis, thrombosis, and vascular biology 1998, 18:1818-1827.
20. Renier G., Skamene E., DeSanctis J., Radzioch D. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities. Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993, 13:1515-1524.
21. Chang C.L., Torrejon C., Jung U.J., Graf K., Deckelbaum R.J. Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice. Atherosclerosis 2014, 234:401-409.
22. Chang C.L., Seo T., Du C.B., Accili D., Deckelbaum R.J. n-3 Fatty acids decrease arterial low-density lipoprotein cholesterol delivery and lipoprotein lipase levels in insulin-resistant mice. Arteriosclerosis, thrombosis, and vascular biology 2010, 30:2510-2517.
23. Chang C.L., Seo T., Matsuzaki M., Worgall T.S., Deckelbaum R.J. n-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution. Arteriosclerosis, thrombosis, and vascular biology 2009, 29:555-561.
24. Van Eck M., Zimmermann R., Groot P.H., Zechner R., Van Berkel T.J. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 2000, 20:E53-62.
25. Babaev V.R., Fazio S., Gleaves L.A., Carter K.J., Semenkovich C.F., Linton M.F. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. The Journal of clinical investigation 1999, 103:1697-1705.
26. Makoveichuk E., Castel S., Vilaro S., Olivecrona G. Lipoprotein lipase-dependent binding and uptake of low density lipoproteins by THP-1 monocytes and macrophages: possible involvement of lipid rafts. Biochimica et biophysica acta 2004, 1686:37-49.
27. Olivier M., Tanck M.W., Out R., et al. Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formation. Arteriosclerosis, thrombosis, and vascular biology 2012, 32:2223-2231.
28. Chen W., Jump D.B., Esselman W.J., Busik J.V. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Investigative ophthalmology & visual science 2007, 48:18-26.
29. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Goldberg I.J., Steinberg D., Witztum J.L. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:10143-10147.
30. Michaud S.E., Renier G. Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. Diabetes 2001, 50:660-666.
31. Bojic L.A., Sawyez C.G., Telford D.E., Edwards J.Y., Hegele R.A., Huff M.W. Activation of peroxisome proliferator-activated receptor delta inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein. Arteriosclerosis, thrombosis, and vascular biology 2012, 32:2919-2928.
32. Li H., Ruan X.Z., Powis S.H., et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney international 2005, 67:867-874.
33. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.M., et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. The EMBO journal 1996, 15:5336-5348.
34. Ziouzenkova O., Perrey S., Asatryan L., et al. Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2730-2735.
35. Oh D.Y., Talukdar S., Bae E.J., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.